Earnings Summary

Novo Nordisk A/S’s revenue fell -100% since last year same period to $0Mn in the Q1 2023. On a quarterly growth basis, Novo Nordisk A/S has generated -100% fall in its revenue since last 3-months.

Novo Nordisk A/S’s net profit jumped 39.44% since last year same period to $19814Mn in the Q1 2023. On a quarterly growth basis, Novo Nordisk A/S has generated 45.78% jump in its net profits since last 3-months.

Novo Nordisk A/S’s net profit margin jumped 234427088992.19% since last year same period to 79256000000% in the Q1 2023. On a quarterly growth basis, Novo Nordisk A/S has generated 280428159994.17% jump in its net profit margins since last 3-months.

Novo Nordisk A/S’s price-to-earnings ratio after this Q1 2023 earnings stands at 41.89.

Novo Nordisk A/S’s earning per share (EPS) estimates for the current quarter stand at 1.12 - a 10.89% jump from last quarter’s estimates.

Novo Nordisk A/S’s earning per share (EPS) estimates for the current year stand at 1.12.

Novo Nordisk A/S’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2023. This indicates that the Novo Nordisk A/S has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.